Document is current
Any future updates will be listed below
-
Authors
Pagano, Livio https://orcid.org/0000-0001-8287-928X
Maschmeyer, Georg https://orcid.org/0000-0003-2378-2466
Lamoth, Frederic https://orcid.org/0000-0002-1023-5597
Blennow, Ola https://orcid.org/0000-0002-7167-7882
Xhaard, Alienor https://orcid.org/0000-0002-4449-989X
Spadea, Manuela https://orcid.org/0000-0001-7728-904X
Busca, Alessandro https://orcid.org/0000-0001-5361-5613
Cordonnier, Catherine https://orcid.org/0000-0002-3216-5470
Maertens, Johan https://orcid.org/0000-0003-4257-5980
,
Guisado, Manuela Aguilar
Akova, Murat
Alain, Sophie
Aljurf, Mahmoud
Averbuch, Dina
Baccelli, Francesco
Blijlevens, Nicole
Boeckh, Michael
Calandra, Thierry
Cesaro, Simone
Chemaly, Roy
Compagno, Francesca
De La Camara, Rafael
de Silva, Thushan
de Morais Guerreiro, Manuel Nuno Direito
Galaverna, Federica
Vidal, Carolina Garcia
Gedde-Dahl, Tobias
Gil, Lidia
Groll, Andreas
Herbrecht, Raoul
Hirsch, Hans
Hoenigl, Martin
Ljungman, Per
Mehra, Varun
Mikulska, Malgorzata
Munoz, Patricia
Myrhe, Anders Eivind Leren
Navarro, David
Neofytos, Dionysios
Nucci, Marcio
Oltolini, Chiara
Piekarska, Agnieszka
Pinana, José Luis
Ramirez, Elena Reigadas
Robin, Christine
Sadowska-Klasa, Alicja
Spadea, Manuela
Teh, Ben
Vanbiervliet, Yuri
White, Lewis
- License Information
-
More Information
Article History
Received: 7 February 2025
Revised: 27 February 2025
Accepted: 24 March 2025
First Online: 9 April 2025
Competing interests
: Livio Pagano (LP) was Board member of Gilead Science, MSD, Pfizer, Menarini-Stemline, Gentili, Jazz Pharmaceutical, Cidara and has received speaker’s honoraria from Gilead Sciences, Kyowa Kirin, MSD, Pfizer Pharmaceuticals, Astellas Pharma, Novartis, Jazz Pharmaceutical, Janseen-Cilag, Astra Zeneca, F2G, Abbvie. Consultant for Menarini, Cidara. Georg Maschmeyer (GM) has received speaker’s honoraria from Gilead Sciences. Frederic Lamoth (FL) reports research funding from Gilead, MSD, Pfizer and Novartis, and honoraria for conferences or advisory boards from Gilead, MSD, Pfizer, Mundipharma and Becton-Dickinson, outside of the submitted work. All contracts were made with and fees paid to his institution (CHUV). Ola Blennow has received speaker’s honoraria from Gilead Sciences. Alienor Xhaard (AX) has received speaker’s honoraria from Merck Sharp and Dohme and Pfizer Pharmaceuticals. Manuela spadea (MS) nothing to declare. Alessandro Busca (AB) was Board member of Gilead Science, Takeda, and has received speaker’s honoraria from Gilead Kite Sciences, MSD, Pfizer Pharmaceuticals, Novartis, Jazz Pharmaceutical, Astra-Zeneca, Abbvie, Menarini Stemline, Takeda. Catherine Cordonnier (CC) has received speaker’s honoraria from Gilead Science and MSD, and consulting fees from Cidara and Mundipharma. Johan Maertens (JM) reports consulting fees from Amplyx, Cidara, Gilead, Pfizer, Scynexis, F2G, Mundipharma, Takeda, and Basilea; Honoraria for lectures from Astellas, Gilead, Basilea, Mundipharma, Takeda, MedScape, Pfizer, and Shionogi; Participation on Advisory Board from Cidara, Pulmocide, Shionogi, Basilea, Sfunga.
: Livio Pagano, Georg Maschmeyer, Frederic Lamoth, Ola Blennow, Alienor Xhaard, Manuela Spadea, Alessandro Busca, Catherine Cordonnier, Johan Maertens.
